WallStreetZenWallStreetZen

NASDAQ: ACB
Aurora Cannabis Inc Stock

$0.51-0.01 (-1.92%)
Updated Jun 5, 2023
ACB Price
$0.51
Fair Value Price
$1.31
Market Cap
$175.27M
52 Week Low
$0.49
52 Week High
$1.94
P/E
-0.09x
P/B
0.42x
P/S
1.8x
PEG
N/A
Dividend Yield
N/A
Revenue
$159.09M
Earnings
-$1.28B
Gross Margin
-13.1%
Operating Margin
-806.45%
Profit Margin
-829%
Debt to Equity
0.77
Operating Cash Flow
-$115M
Beta
1.47
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

ACB Overview

Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ACB scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ACB ($0.51) is undervalued by 60.67% relative to our estimate of its Fair Value price of $1.31 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
ACB ($0.51) is significantly undervalued by 60.67% relative to our estimate of its Fair Value price of $1.31 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
ACB is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ACB due diligence checks available for Premium users.

Be the first to know about important ACB news, forecast changes, insider trades & much more!

ACB News

Valuation

ACB fair value

Fair Value of ACB stock based on Discounted Cash Flow (DCF)
Price
$0.51
Fair Value
$1.31
Undervalued by
60.97%
ACB ($0.51) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ACB ($0.51) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ACB is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ACB price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.09x
Industry
14.98x
Market
53.21x

ACB price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.42x
Industry
1.78x
ACB is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ACB's financial health

Profit margin

Revenue
$45.0M
Net Income
-$51.7M
Profit Margin
-114.7%
ACB's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ACB's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$747.3M
Liabilities
$313.0M
Debt to equity
0.77
ACB's short-term assets ($408.11M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ACB's short-term assets ($408.11M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ACB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$44.3M
Investing
$10.6M
Financing
-$45.5M
ACB's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ACB vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
ACB$175.27M-0.19%-0.09x0.42x
BGXX$160.82M-3.05%-4.85x13.68x
ZOM$193.05M+0.51%-8.57x0.73x
DRRX$141.31M+0.26%-3.72x9.21x
PRPH$139.35M-5.48%19.78x2.32x

Aurora Cannabis Stock FAQ

What is Aurora Cannabis's quote symbol?

(NASDAQ: ACB) Aurora Cannabis trades on the NASDAQ under the ticker symbol ACB. Aurora Cannabis stock quotes can also be displayed as NASDAQ: ACB.

If you're new to stock investing, here's how to buy Aurora Cannabis stock.

What is the 52 week high and low for Aurora Cannabis (NASDAQ: ACB)?

(NASDAQ: ACB) Aurora Cannabis's 52-week high was $1.94, and its 52-week low was $0.49. It is currently -73.51% from its 52-week high and 4.9% from its 52-week low.

How much is Aurora Cannabis stock worth today?

(NASDAQ: ACB) Aurora Cannabis currently has 340,987,434 outstanding shares. With Aurora Cannabis stock trading at $0.51 per share, the total value of Aurora Cannabis stock (market capitalization) is $175.27M.

Aurora Cannabis stock was originally listed at a price of $7.21 in Jul 15, 2014. If you had invested in Aurora Cannabis stock at $7.21, your return over the last 8 years would have been -92.87%, for an annualized return of -28.12% (not including any dividends or dividend reinvestments).

How much is Aurora Cannabis's stock price per share?

(NASDAQ: ACB) Aurora Cannabis stock price per share is $0.51 today (as of Jun 5, 2023).

What is Aurora Cannabis's Market Cap?

(NASDAQ: ACB) Aurora Cannabis's market cap is $175.27M, as of Jun 6, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Aurora Cannabis's market cap is calculated by multiplying ACB's current stock price of $0.51 by ACB's total outstanding shares of 340,987,434.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.